EXAS Relative Valuation
EXAS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, EXAS is overvalued; if below, it's undervalued.
Historical Valuation
Exact Sciences Corp (EXAS) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -55.64. The fair price of Exact Sciences Corp (EXAS) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：101.25
Fair
119.94
PE
1Y
3Y
5Y
Trailing
Forward
35.97
EV/EBITDA
Exact Sciences Corp. (EXAS) has a current EV/EBITDA of 35.97. The 5-year average EV/EBITDA is 0.73. The thresholds are as follows: Strongly Undervalued below -141.60, Undervalued between -141.60 and -70.44, Fairly Valued between 71.89 and -70.44, Overvalued between 71.89 and 143.06, and Strongly Overvalued above 143.06. The current Forward EV/EBITDA of 35.97 falls within the Historic Trend Line -Fairly Valued range.
-1251.84
EV/EBIT
Exact Sciences Corp. (EXAS) has a current EV/EBIT of -1251.84. The 5-year average EV/EBIT is -117.98. The thresholds are as follows: Strongly Undervalued below -513.52, Undervalued between -513.52 and -315.75, Fairly Valued between 79.79 and -315.75, Overvalued between 79.79 and 277.56, and Strongly Overvalued above 277.56. The current Forward EV/EBIT of -1251.84 falls within the Strongly Undervalued range.
5.37
PS
Exact Sciences Corp. (EXAS) has a current PS of 5.37. The 5-year average PS is 5.51. The thresholds are as follows: Strongly Undervalued below -0.57, Undervalued between -0.57 and 2.47, Fairly Valued between 8.55 and 2.47, Overvalued between 8.55 and 11.59, and Strongly Overvalued above 11.59. The current Forward PS of 5.37 falls within the Historic Trend Line -Fairly Valued range.
40.84
P/OCF
Exact Sciences Corp. (EXAS) has a current P/OCF of 40.84. The 5-year average P/OCF is 15.33. The thresholds are as follows: Strongly Undervalued below -114.25, Undervalued between -114.25 and -49.46, Fairly Valued between 80.12 and -49.46, Overvalued between 80.12 and 144.91, and Strongly Overvalued above 144.91. The current Forward P/OCF of 40.84 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Exact Sciences Corp. (EXAS) has a current P/FCF of 0.00. The 5-year average P/FCF is 9.32. The thresholds are as follows: Strongly Undervalued below -400.50, Undervalued between -400.50 and -195.59, Fairly Valued between 214.23 and -195.59, Overvalued between 214.23 and 419.14, and Strongly Overvalued above 419.14. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Exact Sciences Corp (EXAS) has a current Price-to-Book (P/B) ratio of 7.67. Compared to its 3-year average P/B ratio of 3.89 , the current P/B ratio is approximately 96.91% higher. Relative to its 5-year average P/B ratio of 4.22, the current P/B ratio is about 81.57% higher. Exact Sciences Corp (EXAS) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -0.20%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -0.96% , the current FCF yield is about -100.00% lower.
7.66
P/B
Median3y
3.89
Median5y
4.22
1.29
FCF Yield
Median3y
-0.20
Median5y
-0.96
Competitors Valuation Multiple
The average P/S ratio for EXAS's competitors is , providing a benchmark for relative valuation. Exact Sciences Corp Corp (EXAS) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 20.05%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of EXAS increased by 79.98% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -8.84 to -19.21.
The secondary factor is the Revenue Growth, contributed 20.05%to the performance.
Overall, the performance of EXAS in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Exact Sciences Corp (EXAS) currently overvalued or undervalued?
What is Exact Sciences Corp (EXAS) fair value?
How does EXAS's valuation metrics compare to the industry average?
What is the current P/B ratio for Exact Sciences Corp (EXAS) as of Dec 05 2025?
What is the current FCF Yield for Exact Sciences Corp (EXAS) as of Dec 05 2025?
What is the current Forward P/E ratio for Exact Sciences Corp (EXAS) as of Dec 05 2025?